Aimei Health Technology Net Income
| AFJK Stock | 48.46 0.62 1.30% |
As of the 10th of February, Aimei Health shows the Risk Adjusted Performance of 0.1126, mean deviation of 37.35, and Downside Deviation of 15.76. Aimei Health Technology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from Aimei Health's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aimei Health's valuation are summarized below:Aimei Health Technology does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Income | 2.9 M | 1.5 M | |
| Net Income From Continuing Ops | 2.3 M | 2 M | |
| Net Income Per Share | 0.25 | 0.27 |
Historical Net Income data for Aimei Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Aimei Health Technology represents a compelling investment opportunity.
Latest Aimei Health's Net Income Growth Pattern
Below is the plot of the Net Income of Aimei Health Technology over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Aimei Health Technology financial statement analysis. It represents the amount of money remaining after all of Aimei Health Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Aimei Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aimei Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 2.55 M | 10 Years Trend |
|
Net Income |
| Timeline |
Aimei Net Income Regression Statistics
| Arithmetic Mean | 552,007 | |
| Geometric Mean | 269,726 | |
| Coefficient Of Variation | 160.76 | |
| Mean Deviation | 626,899 | |
| Median | 171,389 | |
| Standard Deviation | 887,430 | |
| Sample Variance | 787.5B | |
| Range | 2.8M | |
| R-Value | 0.62 | |
| Mean Square Error | 520.2B | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | 108,430 | |
| Total Sum of Squares | 12.6T |
Aimei Net Income History
Other Fundumenentals of Aimei Health Technology
Aimei Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Aimei Health is extremely important. It helps to project a fair market value of Aimei Stock properly, considering its historical fundamentals such as Net Income. Since Aimei Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aimei Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aimei Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aimei Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Aimei Health Technology requires distinguishing between market price and book value, where the latter reflects Aimei's accounting equity. The concept of intrinsic value - what Aimei Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aimei Health's price substantially above or below its fundamental value.
Understanding that Aimei Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aimei Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aimei Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Aimei Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aimei Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aimei Health.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Aimei Health on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Aimei Health Technology or generate 0.0% return on investment in Aimei Health over 90 days. Aimei Health is related to or competes with Oak Woods, Eureka Acquisition, Central Plains, CSLM Digital, Bayview Acquisition, Origin Investment, and Ribbon Acquisition. Aimei Health is entity of United States. It is traded as Stock on NASDAQ exchange. More
Aimei Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aimei Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aimei Health Technology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 15.76 | |||
| Information Ratio | 0.1272 | |||
| Maximum Drawdown | 1067.02 | |||
| Value At Risk | (22.49) | |||
| Potential Upside | 60.89 |
Aimei Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aimei Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aimei Health's standard deviation. In reality, there are many statistical measures that can use Aimei Health historical prices to predict the future Aimei Health's volatility.| Risk Adjusted Performance | 0.1126 | |||
| Jensen Alpha | 14.46 | |||
| Total Risk Alpha | 2.24 | |||
| Sortino Ratio | 1.02 | |||
| Treynor Ratio | 0.8665 |
Aimei Health February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1126 | |||
| Market Risk Adjusted Performance | 0.8765 | |||
| Mean Deviation | 37.35 | |||
| Semi Deviation | 12.44 | |||
| Downside Deviation | 15.76 | |||
| Coefficient Of Variation | 781.25 | |||
| Standard Deviation | 125.88 | |||
| Variance | 15845.33 | |||
| Information Ratio | 0.1272 | |||
| Jensen Alpha | 14.46 | |||
| Total Risk Alpha | 2.24 | |||
| Sortino Ratio | 1.02 | |||
| Treynor Ratio | 0.8665 | |||
| Maximum Drawdown | 1067.02 | |||
| Value At Risk | (22.49) | |||
| Potential Upside | 60.89 | |||
| Downside Variance | 248.3 | |||
| Semi Variance | 154.84 | |||
| Expected Short fall | (55.28) | |||
| Skewness | 7.72 | |||
| Kurtosis | 61.46 |
Aimei Health Technology Backtested Returns
Aimei Health is out of control given 3 months investment horizon. Aimei Health Technology secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We are able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 16.95% are justified by taking the suggested risk. Use Aimei Health Downside Deviation of 15.76, risk adjusted performance of 0.1126, and Mean Deviation of 37.35 to evaluate company specific risk that cannot be diversified away. Aimei Health holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 18.58, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aimei Health will likely underperform. Use Aimei Health total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to analyze future returns on Aimei Health.
Auto-correlation | -0.38 |
Poor reverse predictability
Aimei Health Technology has poor reverse predictability. Overlapping area represents the amount of predictability between Aimei Health time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aimei Health Technology price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Aimei Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 105.54 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Aimei Operating Income
Based on the recorded statements, Aimei Health Technology reported net income of 2.55 M. This is 99.8% lower than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 99.55% higher than that of the company.
Aimei Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aimei Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aimei Health could also be used in its relative valuation, which is a method of valuing Aimei Health by comparing valuation metrics of similar companies.Aimei Health is currently under evaluation in net income category among its peers.
Aimei Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Aimei Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Aimei Health's managers, analysts, and investors.Environmental | Governance | Social |
Aimei Fundamentals
| Return On Asset | -0.0104 | ||||
| Current Valuation | 307.74 M | ||||
| Shares Outstanding | 6.12 M | ||||
| Shares Owned By Insiders | 33.60 % | ||||
| Shares Owned By Institutions | 44.34 % | ||||
| Number Of Shares Shorted | 18.58 K | ||||
| Price To Book | 7.29 X | ||||
| EBITDA | (1.06 M) | ||||
| Net Income | 2.55 M | ||||
| Total Debt | 227.7 K | ||||
| Book Value Per Share | (0.56) X | ||||
| Cash Flow From Operations | (672.29 K) | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 0.20 X | ||||
| Beta | -3.7 | ||||
| Market Capitalization | 296.66 M | ||||
| Total Asset | 73.81 M | ||||
| Retained Earnings | (1.48 M) | ||||
| Working Capital | (786.61 K) | ||||
| Net Asset | 73.81 M |
About Aimei Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aimei Health Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aimei Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aimei Health Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aimei Health. If investors know Aimei will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aimei Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Aimei Health Technology requires distinguishing between market price and book value, where the latter reflects Aimei's accounting equity. The concept of intrinsic value - what Aimei Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aimei Health's price substantially above or below its fundamental value.
Understanding that Aimei Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aimei Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aimei Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.